| Market Cap | 47.22M | P/E | 7.78 | EPS this Y | 1,133.30% | Ern Qtrly Grth | 422.40% |
| Income | 6.64M | Forward P/E | 10.67 | EPS next Y | 54.10% | 50D Avg Chg | -4.00% |
| Sales | 36.37M | PEG | - | EPS past 5Y | 62.99% | 200D Avg Chg | -52.00% |
| Dividend | N/A | Price/Book | 1.02 | EPS next 5Y | - | 52W High Chg | -81.00% |
| Recommedations | 2.00 | Quick Ratio | 7.96 | Shares Outstanding | 16.39M | 52W Low Chg | 26.00% |
| Insider Own | 19.01% | ROA | 9.70% | Shares Float | 13.11M | Beta | 1.06 |
| Inst Own | 20.45% | ROE | 13.44% | Shares Shorted/Prior | 491.45K/469.28K | Price | 2.88 |
| Gross Margin | 60.23% | Profit Margin | 18.27% | Avg. Volume | 192,587 | Target Price | 10.67 |
| Oper. Margin | 40.84% | Earnings Date | Nov 7 | Volume | 26,692 | Change | 0.00% |
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
| HC Wainwright & Co. | Buy | Aug 12, 24 |
| HC Wainwright & Co. | Buy | May 13, 24 |
| Maxim Group | Buy | May 10, 24 |
| HC Wainwright & Co. | Buy | Nov 13, 23 |
| HC Wainwright & Co. | Buy | Aug 7, 23 |
| HC Wainwright & Co. | Buy | May 4, 23 |
| Alliance Global Partners | Buy | May 4, 23 |
| HC Wainwright & Co. | Buy | Feb 10, 23 |
| Alliance Global Partners | Buy | Feb 10, 23 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Sardano Joseph C | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Sep 14 | Buy | 2.8773 | 10,000 | 28,773 | 1,175,293 | 09/18/23 |
| Heinrich John | Director Director | May 11 | Buy | 2.86 | 10,000 | 28,600 | 79,940 | 05/31/23 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | May 09 | Buy | 2.99 | 25,000 | 74,750 | 1,155,293 | 05/11/23 |
| O'Rear Samuel | Director Director | May 08 | Buy | 2.97 | 20,000 | 59,400 | 143,570 | 05/10/23 |
| Sardano Michael | PRESIDENT AND GENERA.. PRESIDENT AND GENERAL COUNSEL | May 08 | Buy | 2.9950 | 1,000 | 2,995 | 56,774 | 05/10/23 |
| Sardano Michael | PRESIDENT AND GENERA.. PRESIDENT AND GENERAL COUNSEL | Sep 13 | Option | 5.55 | 5,000 | 27,750 | 54,519 | 09/15/22 |
| Sardano Michael | PRESIDENT AND GENERA.. PRESIDENT AND GENERAL COUNSEL | Sep 13 | Sell | 14.13 | 5,000 | 70,650 | 49,519 | 09/15/22 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Aug 09 | Sell | 14.11 | 158,412 | 2,235,193 | 1,171,881 | 08/11/22 |
| McCall William H | Director Director | May 10 | Sell | 7.54 | 10,000 | 75,400 | 325,723 | 05/12/22 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Mar 10 | Sell | 10.16 | 133,356 | 1,354,897 | 1,330,293 | 03/11/22 |
| Soro Nicolas | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Mar 09 | Option | 5.55 | 10,000 | 55,500 | 13,546 | 03/10/22 |
| Soro Nicolas | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Mar 09 | Sell | 10.2 | 10,000 | 102,000 | 3,546 | 03/10/22 |
| Rampolla Javier | CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER | Mar 04 | Option | 5.5 | 9,000 | 49,500 | 52,049 | 03/08/22 |
| Rampolla Javier | CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER | Mar 04 | Sell | 9.42 | 9,000 | 84,780 | 61,049 | 03/08/22 |